Last reviewed · How we verify
NCT05154279
The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
NA trial testing Terlipressin in Laparoscopic Myomectomy in 99 participants. Status unknown.
30 December 2024
Quick facts
| Lead sponsor | Wael Elbanna Clinic |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 99 |
| Start date | 27 February 2022 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 March 2026 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- Terlipressin — full drug profile →
Conditions studied
- Laparoscopic Myomectomy — all drugs for Laparoscopic Myomectomy →
Sponsor
Wael Elbanna Clinic
Who can join
Adults 16 to 45, female only, with Laparoscopic Myomectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our study aims to evaluate the efficacy of intramyometrial injection of Terlipressin versus intramyometrial injection of Carbetocin on hemoglobin level in women undergoing abdominal myomectomy. Moreover, to evaluate their efficacy in decreasing blood loss on operative time and to describe the injection sequelae for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05154279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Terlipressin
Trials testing the same drug.
- NCT07304466 — Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation · NA · not yet recruiting
- NCT06556472 — Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving · NA · not yet recruiting
- NCT03130127 — Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis · NA · unknown
- NCT06108362 — Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients · Phase 4 · unknown
- NCT05315557 — Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic · NA · unknown
Other recruiting trials for Laparoscopic Myomectomy
Currently open trials in the same condition.
- NCT07200778 — Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping · NA · recruiting
Other Wael Elbanna Clinic trials
Trials by the same sponsor.
- NCT05170230 — The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic · NA · recruiting
- NCT05242783 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · completed
- NCT05266534 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · recruiting
- NCT05050747 — Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle · completed
- NCT05014867 — Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Pr · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05154279 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wael Elbanna Clinic
- Last refreshed: 25 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05154279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing